Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 290 of the 290 references it cites were found in a registry or an index.

Lipoprotein(a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biology

Open access
Nordestgaard, Børge G., Langsted, Anne · 2016 · Journal of Lipid Research

Abstract

Scanu, and colleagues cloned and sequenced the LPA gene coding for apo(a) (4, 5), a protein with homology to plasminogen, which accounts for the difference between an Lp(a) particle and an LDL particle.These observations generated a huge scientific interest in Lp(a), leading to an exponential growth in the number of articles published, which then later declined again.Renewed interested in Lp(a) came in 2009 from Pia Kamstrup et al. ( 6) with genetic evidence from Mendelian randomization that high Lp(a) is causally associated with cardiovascular disease, from the Emerging Risk Factors Collaboration led by John Danesh that Lp(a) epidemiologically is continuously and independently associated with cardiovascular disease risk (7), and from Robert Clarke et al. (8) that of 2,100 candidate genes for cardiovascular disease, genetic variation in the LPA gene was the strongest genetic cardiovascular risk factor.Following the publication of these studies, high concentrations of Lp(a) have been considered to be a direct cause of cardiovascular disease, just like high LDL cholesterol concentrations.Genetic evidence largely free of confounding and fully free of reverse causation, two major problems of observational epidemiology, is what has cemented the understanding of causality of Lp(a) for cardiovascular disease.These novel and important findings led the European Atherosclerosis Society to publish a 2010 consensus panel statement recommending screening for elevated Lp(a) in individuals at intermediate, high, or very high cardiovascular risk, and suggested a desirable plasma concentration of less than 50 mg/dl (9).Of note, we naturally were fully aware that the risk of cardiovascular disease increases already at Lp(a) levels above 30 mg/dl, but to get the attention of the clinical community, we believed it was the best strategy to start focusing on individuals with the highest cardiovascular risk, that is, the 20% of individuals with concentrations above 50 mg/dl.Abstract Human epidemiologic and genetic evidence using the Mendelian randomization approach in large-scale studies now strongly supports that elevated lipoprotein (a) [Lp(a)] is a causal risk factor for cardiovascular disease, that is, for myocardial infarction, atherosclerotic stenosis, and aortic valve stenosis.The Mendelian randomization approach used to infer causality is generally not affected by confounding and reverse causation, the major problems of observational epidemiology.This approach is particularly valuable to study causality of Lp(a), as single genetic variants exist that explain 27-28% of all variation in plasma Lp(a).The most important genetic variant likely is the kringle IV type 2 (KIV-2) copy number variant, as the apo(a) product of this variant influences fibrinolysis and thereby thrombosis, as opposed to the Lp(a) particle per se.We speculate that the physiological role of KIV-2 in Lp(a) could be through wound healing during childbirth, infections, and injury, a role that, in addition, could lead to more blood clots promoting stenosis of arteries and the aortic valve, and myocardial infarction.Randomized placebo-controlled trials of Lp(a) reduction in individuals with very high concentrations to reduce cardiovascular disease are awaited.Recent genetic evidence documents elevated Lp(a) as a cause of myocardial infarction, atherosclerotic stenosis, and aortic valve stenosis.-Nordestgaard,B. G., and A. Langsted.Lipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biology.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1194/jlr.r071233

Cites

290 of 290 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 290 references

Cited by

See all 575

Metadata

Authors
Nordestgaard, B. G., & Langsted, A.
Affiliations
University of Copenhagen (DK)
Corresponding author
Nordestgaard, Børge G.
Venue
Journal of Lipid Research
Publisher
Elsevier BV
Published
2016-11
Volume
57
Issue
11
Pages
1953-1975
ISSN
0022-2275 (ISSN-L)
OpenAlex
W2526556731
Cited by
575
References
290
Citations by year
2026: 46 · 2025: 66 · 2024: 72 · 2023: 65 · 2022: 72 · 2021: 59 · 2020: 67 · 2019: 60 · 2018: 37 · 2017: 28 · 2016: 2
FWCI
8.35
Type
journal article
Language
en
Open access
Licence
Locations
  • Journal of Lipid Research (publishedVersion, cc-by)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
  • Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
Keywords
lipoprotein(a), cardiovascular disease, causal risk factors, LPA gene, Mendelian randomization, genetic association, plasminogen homology, aortic stenosis, myocardial infarction, atherosclerotic stenosis, Lp(a) screening, LDL cholesterol, reverse causality, confounding
MeSH terms
Aortic Valve Stenosis, Cardiovascular Diseases, Humans, Myocardial Infarction, Risk Factors, Lipoprotein(a), Genetic Predisposition to Disease, DNA Copy Number Variations

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Lipoprotein(a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biology. https://app.cochat.ai/papers/10.1194/jlr.r071233
The paper
Nordestgaard, B. G., & Langsted, A. (2016). Lipoprotein(a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biology. Journal of Lipid Research. https://doi.org/10.1194/jlr.r071233

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.